MSCI 608

DEV & COMM OF HUMAN THERAP

2credits
About this course

Development and Commercialization of Human Therapeutics. (2-0). Credit 2. Survey the principles and concepts of commercializing a human pharmaceutical drug within the context of a startup biotechnology; emphasis on the issues and concepts encountered in either academic or industrial careers in moving potential pharmaceutical drug towards approved therapeutic.

All available terms

1 term

Avg. GPA
3.92
Grades
13
More course details

Texas A&M

MSCI 608 at TAMU: average GPA 3.92 across 13 students. Grade distribution by term. Development and Commercialization of Human Therapeutics. (2-0). Credit 2…

Average GPA: 3.92

Grade distribution records: 13 students across 1 terms.

Grade distribution

GradeStudentsPercent
A1292.3%
B17.7%

Based on 13 student grade records across 1 term and 1 professor.

Instructors

  • Arora S 13 students, Average GPA 3.92

The course page is taking longer to load. This summary is still available.

We could not load the full course details. This summary is still available.

Still loading. This can take a moment on a slow connection.

Loading My Class Grades